Odyssey Health (ODYY) Return on Sales (2014 - 2017)

Odyssey Health has disclosed Return on Sales across 4 years of filings, most recently posting 0.11% for Q2 2017.

• Quarterly Return on Sales fell 11.0% year-over-year to 0.11% in Q2 2017, while the trailing twelve-month figure through Apr 2017 was 0.11% (down 8.0% YoY) and the FY2016 annual result came in at 0.02%, down 2.0% from the prior year.
• Return on Sales declined to 0.11% in Q2 2017, from 0.03% in the prior quarter.
• Across five years, Return on Sales topped out at 0.0% in Q4 2014 and bottomed at 0.11% in Q2 2017.
• The 4-year median for Return on Sales is 0.02% (2016), against an average of 0.03%.
• The widest YoY moves for Return on Sales: up 3 bps in 2017, down 11 bps in 2017.
• Odyssey Health's Return on Sales stood at 0.0% in 2014, then tumbled by 280 bps to 0.01% in 2015, then plunged by 85 bps to 0.02% in 2016, then plunged by 413 bps to 0.11% in 2017.
• According to Business Quant data, Return on Sales over the past three periods registered 0.11%, 0.03%, and 0.02% for Q2 2017, Q1 2017, and Q4 2016 respectively.